lomefloxacin has been researched along with Bacterial Infections, Gram-Negative in 5 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine centers in Italy participated in a worldwide, multicenter study comparing the effectiveness and safety of lomefloxacin and amoxicillin in patients with acute exacerbations of chronic bronchitis caused mainly by gram-negative pathogens." | 9.07 | Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. ( Albera, C; Grassi, C; Pozzi, E, 1992) |
| "Lomefloxacin has been shown to produce high and sustained concentrations in serum and bronchial mucosa after once-daily administration." | 6.67 | A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology. ( Kemper, P; Köhler, D, 1992) |
| "Nine centers in Italy participated in a worldwide, multicenter study comparing the effectiveness and safety of lomefloxacin and amoxicillin in patients with acute exacerbations of chronic bronchitis caused mainly by gram-negative pathogens." | 5.07 | Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. ( Albera, C; Grassi, C; Pozzi, E, 1992) |
| "Lomefloxacin has been shown to produce high and sustained concentrations in serum and bronchial mucosa after once-daily administration." | 2.67 | A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology. ( Kemper, P; Köhler, D, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, WC | 1 |
| Chiang, SR | 1 |
| Lee, HC | 1 |
| Tang, HJ | 1 |
| Wang, YY | 1 |
| Chuang, YC | 1 |
| Belliveau, P | 1 |
| Nightingale, CH | 1 |
| Quintiliani, R | 1 |
| Crowe, H | 1 |
| Gousee, G | 1 |
| Spivey, IM | 1 |
| Grassi, C | 1 |
| Albera, C | 1 |
| Pozzi, E | 1 |
| Kemper, P | 1 |
| Köhler, D | 1 |
1 review available for lomefloxacin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Drug Tolerance; Female; Fluo | 1993 |
2 trials available for lomefloxacin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chroni | 1992 |
A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic | 1992 |
2 other studies available for lomefloxacin and Bacterial Infections, Gram-Negative
| Article | Year |
|---|---|
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxi | 2003 |
Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infectio | 1993 |